# Celldex Therapeutics, Inc.: filings

CLDX · Nasdaq · CIK 744218 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cldx.md) · [Financials](/companies/cldx/financials.md) · [Filings](/companies/cldx/filings.md) · [Insiders](/companies/cldx/insiders.md)

## Reports and events: 259 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 367, 8-K 163, SC 13G/A 61, 10-Q 53, SC 13G 31, 424B5 29, 3 19, SCHEDULE 13G/A 19, 10-K 18, DEF 14A 18, S-8 14, UPLOAD 14, 144 12, CORRESP 12, EFFECT 7, S-3 6, SCHEDULE 13G 6, CT ORDER 5, S-3/A 5, ARS 4, 10-K/A 3, 424B3 3, S-3ASR 3, S-4/A 3, 425 2, 8-K/A 2, D 2, PRE 14A 2, S-8 POS 2, 10-Q/A 1, 424B2 1, DEFA14A 1, S-3MEF 1, S-4 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-22 | 11:09 ET | [8-K](/filings/0001104659-26-109465.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109465 |
| 2026-08-06 | 20:06 ET | [10-Q](/filings/0001104659-26-091984.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091984 |
| 2026-08-06 | 20:01 ET | [8-K](/filings/0001171843-26-005316.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005316 |
| 2026-07-15 | 20:07 ET | [8-K](/filings/0001104659-26-083880.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-083880 |
| 2026-06-26 | 12:43 ET | [8-K](/filings/0001104659-26-078023.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-078023 |
| 2026-05-07 | 20:07 ET | [10-Q](/filings/0001104659-26-057113.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057113 |
| 2026-05-07 | 20:01 ET | [8-K](/filings/0001171843-26-003153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003153 |
| 2026-04-29 | 12:00 ET | [DEF 14A](/filings/0001104659-26-050884.md) | Proxy statement, period 2026-06-25 | 0001104659-26-050884 |
| 2026-04-02 | 12:08 ET | [8-K](/filings/0001104659-26-038882.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-038882 |
| 2026-02-25 | 21:06 ET | [10-K](/filings/0001104659-26-019652.md) | Annual report, period 2025-12-31 | 0001104659-26-019652 |
| 2026-02-25 | 21:01 ET | [8-K](/filings/0001171843-26-001098.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001098 |
| 2025-11-10 | 21:06 ET | [10-Q](/filings/0001104659-25-109137.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109137 |
| 2025-11-10 | 21:01 ET | [8-K](/filings/0001171843-25-007179.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007179 |
| 2025-08-19 | 20:04 ET | [8-K](/filings/0001104659-25-080248.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-080248 |
| 2025-08-07 | 20:06 ET | [10-Q](/filings/0001410578-25-001610.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001610 |
| 2025-08-07 | 20:02 ET | [8-K](/filings/0001171843-25-005181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005181 |
| 2025-06-06 | 12:05 ET | [8-K](/filings/0001104659-25-057066.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-057066 |
| 2025-05-08 | 20:06 ET | [10-Q](/filings/0001410578-25-001111.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001111 |
| 2025-05-08 | 20:01 ET | [8-K](/filings/0001171843-25-002980.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002980 |
| 2025-04-21 | 12:01 ET | [DEF 14A](/filings/0001104659-25-036562.md) | Proxy statement, period 2025-06-05 | 0001104659-25-036562 |
| 2025-02-27 | 21:05 ET | [10-K](/filings/0001410578-25-000216.md) | Annual report, period 2024-12-31 | 0001410578-25-000216 |
| 2025-02-27 | 21:01 ET | [8-K](/filings/0001171843-25-001126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001126 |
| 2024-11-06 | 21:06 ET | [10-Q](/filings/0001410578-24-001766.md) | Quarterly report, period 2024-09-30 | 0001410578-24-001766 |
| 2024-11-06 | 21:01 ET | [8-K](/filings/0001171843-24-006056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006056 |
| 2024-08-08 | 20:05 ET | [10-Q](/filings/0001410578-24-001219.md) | Quarterly report, period 2024-06-30 | 0001410578-24-001219 |
| 2024-08-08 | 20:01 ET | [8-K](/filings/0001171843-24-004603.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004603 |
| 2024-06-14 | 12:00 ET | [8-K](/filings/0001104659-24-071512.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071512 |
| 2024-05-06 | 20:07 ET | [10-Q](/filings/0001410578-24-000593.md) | Quarterly report, period 2024-03-31 | 0001410578-24-000593 |
| 2024-05-06 | 20:01 ET | [8-K](/filings/0001171843-24-002570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002570 |
| 2024-04-25 | 12:00 ET | [DEF 14A](/filings/0001104659-24-051634.md) | Proxy statement, period 2024-06-13 | 0001104659-24-051634 |
| 2024-03-01 | 21:10 ET | [8-K](/filings/0001104659-24-029969.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-029969 |
| 2024-02-26 | 12:05 ET | [10-K](/filings/0001410578-24-000076.md) | Annual report, period 2023-12-31 | 0001410578-24-000076 |
| 2024-02-26 | 12:01 ET | [8-K](/filings/0001171843-24-000966.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-000966 |
| 2023-11-08 | 22:03 ET | [8-K](/filings/0001104659-23-115796.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-115796 |
| 2023-11-06 | 14:00 ET | [8-K](/filings/0001104659-23-114520.md) | 8.01 Other events | 0001104659-23-114520 |
| 2023-11-02 | 20:06 ET | [10-Q](/filings/0001410578-23-002169.md) | Quarterly report, period 2023-09-30 | 0001410578-23-002169 |
| 2023-11-02 | 20:01 ET | [8-K](/filings/0001171843-23-006668.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006668 |
| 2023-08-08 | 20:06 ET | [10-Q](/filings/0001410578-23-001588.md) | Quarterly report, period 2023-06-30 | 0001410578-23-001588 |
| 2023-08-08 | 20:01 ET | [8-K](/filings/0001171843-23-005101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-005101 |
| 2023-06-15 | 20:05 ET | [8-K](/filings/0001104659-23-071597.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-071597 |
| 2023-05-04 | 20:05 ET | [10-Q](/filings/0001104659-23-055992.md) | Quarterly report, period 2023-03-31 | 0001104659-23-055992 |
| 2023-05-04 | 20:01 ET | [8-K](/filings/0001171843-23-002887.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-002887 |
| 2023-04-25 | 12:01 ET | [DEF 14A](/filings/0001104659-23-049299.md) | Proxy statement | 0001104659-23-049299 |
| 2023-03-22 | 22:47 ET | [8-K](/filings/0001104659-23-035198.md) | 8.01 Other events | 0001104659-23-035198 |
| 2023-02-28 | 21:06 ET | [10-K](/filings/0001104659-23-026701.md) | Annual report, period 2022-12-31 | 0001104659-23-026701 |
| 2023-02-28 | 21:01 ET | [8-K](/filings/0001171843-23-001254.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-001254 |
| 2023-02-21 | 21:01 ET | [8-K](/filings/0001104659-23-023768.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-023768 |
| 2022-11-09 | 21:07 ET | [10-Q](/filings/0001104659-22-116466.md) | Quarterly report, period 2022-09-30 | 0001104659-22-116466 |
| 2022-11-09 | 21:02 ET | [8-K](/filings/0001171843-22-007291.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-007291 |
| 2022-08-08 | 20:06 ET | [10-Q](/filings/0001104659-22-087222.md) | Quarterly report, period 2022-06-30 | 0001104659-22-087222 |

Page 1 of 6. [Older](/companies/cldx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:54 ET. No prices; not investment advice.